Seeing Is Believing
XFOR is currently covered by 4 analysts with an average price target of $137.29. This is a potential upside of $133.49 (3512.89%) from yesterday's end of day stock price of $3.8.
X4 Pharmaceuticals's activity chart (see below) currently has 18 price targets and 29 ratings on display. The stock rating distribution of XFOR is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 24 days.
Highest price target for XFOR is $15, Lowest price target is $3.5, average price target is $9.17.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 28-Aug-2025. First documented stock forecast 10-Dec-2017.
Currently out of the existing stock ratings of XFOR, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$9
$5.2 (136.84%)
1 months 27 days ago
(28-Aug-2025)
0/3 (0%)
$5.24 (139.36%)
Buy
$3.5
$-0.3 (-7.89%)
2 months 13 days ago
(12-Aug-2025)
1/2 (50%)
$0.57 (19.45%)
9
Buy
$90
7 months ago
(25-Mar-2025)
0/2 (0%)
$64.35 (250.88%)
Hold
$15
$11.2 (294.74%)
$30
11 months 8 days ago
(17-Nov-2024)
2/2 (100%)
$3.9 (35.14%)
42
Buy
$120
$116.2 (3057.89%)
2 years 5 months 9 days ago
(16-May-2023)
0/1 (0%)
$54 (81.82%)
What is XFOR (X4 Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XFOR (X4 Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XFOR (X4 Pharmaceuticals)?
Which analyst is the currently most bullish on XFOR (X4 Pharmaceuticals)?
Which analyst is the currently most reserved on XFOR (X4 Pharmaceuticals)?